scholarly journals Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer

2016 ◽  
Vol 8 (5) ◽  
pp. 795-802 ◽  
Author(s):  
Hiroaki Kuroda ◽  
Yukinori Sakao ◽  
Mingyon Mun ◽  
Noriko Motoi ◽  
Yuichi Ishikawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Middle Lobe ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung ◽  
Therapeutic Value ◽  
Right Middle Lobe

Limited lymph node dissection in compromised patients of non-small cell lung cancer

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 138
Author(s):  
S Akamine ◽  
T Oka ◽  
T Takahashi ◽  
T Nagayasu ◽  
M Muraoka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung ◽  
Limited Lymph Node Dissection ◽  
Compromised Patients

Surgical outcomes of early-stage small-cell lung cancer: single-center experience

2019 ◽  
Vol 27 (3) ◽  
pp. 187-191
Author(s):  
Muhammet Sayan ◽  
Merve Satir Turk ◽  
Ali Celik ◽  
Ismail Cuneyt Kurul ◽  
Abdullah Irfan Tastepe
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Cell Lung Cancer ◽  
Early Stage ◽  
Mediastinal Lymph Node ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung

Background Small-cell lung cancer is a highly aggressive and metastatic epithelial lung malignancy. A small percentage of these tumors can be detected at an early stage and may be appropriate for surgical treatment. We analyzed the data of patients with early-stage small-cell lung cancer who underwent lobectomy and mediastinal lymph node dissection. Methods Between January 2011 and December 2016, 26 patients with early-stage small-cell lung cancer underwent lobectomy and mediastinal lymph node dissection and were included the study. The mean age was 60.9 years and 18 (69.2%) were male. Patients with increased uptake of 18 F-fludeoxyglucose in mediastinal or distant organs on positron-emission tomography computed tomography, or lung resections other than lobectomy, were not included in the study. Results The most common tumor location was the right upper lobe. The diagnoses were achieved by intraoperative frozen section study in almost all patients (92.3%). Mean overall survival was 58.5 ± 6.7 months (range 45–71 months) and the 5-year survival rate was 53%. We found that a statistically significant correlation between lymph node metastasis in N1 or N2 stations and survival. There was also a significant relationship between N2 nodal metastasis and recurrence. Conclusion As stated in the current guidelines, lung lobectomy and mediastinal lymph node resection should be considered in early-stage small-cell lung cancers. Survival outcomes of surgery for early-stage small-cell lung cancer are similar to the results in non-small-cell lung cancer.

O-102 Systematic lymph node dissection — the standard procedure for stage I and II non-small cell lung cancer (NSCLC)

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S33
Author(s):  
Mikhail I. Davydov ◽  
Boris Polotsky ◽  
Arif Allakhverdiev ◽  
Konstantin Laktionov ◽  
Elhan Suleymanov
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Cell Lung Cancer ◽  
Standard Procedure ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung ◽  
Systematic Lymph Node Dissection
Sign in / Sign up

Export Citation Format

Share Document